D-576-2013 Class III Terminated
FDA drug recall D-576-2013 was initiated by Novartis Consumer Health on Feb 19, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 41,400 Boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 12, 2013
- Initiation Date
- Feb 19, 2013
- Termination Date
- Nov 26, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 41,400 Boxes
Product description
Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438. (Club Pack), NDC 0067-6295-43
Reason for recall
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Distribution pattern
Nationwide and Puerto Rico, and Panama. Military distribution made.
Code information
Lot #: 10109590, 10111050, Exp 2/28/13.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-576-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026